書誌事項
- タイトル別名
-
- Evolving technology for drug delivery system in cardiovascular surgery
- シンゾウ ケッカン ゲカ ニ オケル DDS ギジュツ
この論文をさがす
抄録
There have been variable evolving technologies for drug delivery system (DDS) applied in cardiovascular surgery. Enormous clinical success with drug eluting stent enhanced cardiac surgical researchers to expand the concept of local delivery of effective agents. Representative agents introduced for those technologies include basic fibroblast growth factor(bFGF) and antibiotics, especially vancomycin. With these agents, numerous attempts have been made to treat peripheral tissue ischemia, intractable graft infection, catheter-related infection and to enhance sternal healing process via angiogenesis. Interim results from in vitro and in vivo experiments are promising. Above all, bFGF slow-release system has already launched in clinical arena, and has yielded some therapeutic effect in the treatment of critical limb ischemia. In terms of the DDS application for infection control, antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections have been utilized in Western countries. In this country, gelatin-coated biodegradable polyglycolic acid with bFGF has been tested for the patients undergoing aortic aneurysmal repair to prevent pseudoaneurysmal formation in long term occurring at the aortic anastomotic site.
収録刊行物
-
- Ｄｒｕｇ Ｄｅｌｉｖｅｒｙ Ｓｙｓｔｅｍ
-
Ｄｒｕｇ Ｄｅｌｉｖｅｒｙ Ｓｙｓｔｅｍ 27 (4), 289-295, 2012
日本DDS学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679618866944
-
- NII論文ID
- 130003368324
-
- NII書誌ID
- AN10084591
-
- COI
- 1:CAS:528:DC%2BC38XhvVCmt73L
-
- ISSN
- 18812732
- 09135006
-
- NDL書誌ID
- 024017980
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可